ArticleCancer research communications2025

Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials.

Angélique Vienot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.